sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Wed Jan 21
TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook
2d
Y
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
2d
Y
Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation
2d
Y
CleanSpark (CLSK): Keefe Bruyette Maintains Positive Outlook on Sealy Project Despite ERCOT Batch Study Uncertainty
2d
Y
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
2d
Y
BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends
2d
Y
Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier
2d
Y
Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?
2d
Y
Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds
2d
Y
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
2d
Y
Mahindra Selects Mobileye’s (MBLY) EyeQ6 ADAS for Future Vehicle Lineup
2d
Y
Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market
2d
Y
Is Brighthouse Financial an Underrated Financial Stock Investment Play?
2d
Y
Utz Brands (UTZ) Q4 2025 Earnings Call Transcript
2d
Y
Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates
2d
Y
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
2d
Y
Morgan Stanley Positive on Cipher Mining (CIFR) Data Center Potential
2d
Y
Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory
2d
Y
Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating
2d
Y
Analysts Bullish on Vera Therapeutics (VERA) Amid New Commercial Chief Appointment
2d
Y
Morgan Stanley Cautious on Nebius (NBIS) Following NVIDIA Platform Deployment
2d
Y
TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections
2d
Y
ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change
2d
Y
Critical Report on Ondas (ONDS) Precedes Defense Unit’s $30M Contract in Israel
2d
Y
eBay Q4 Earnings Call Highlights
2d
Y
DoorDash Q4 Earnings Call Highlights
2d
Y
Amplitude Q4 Earnings Call Highlights
2d
Y
Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment
2d
Y
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
2d
Y
Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug
2d
Y
Why Tactile Systems Technology Stock Surged by Nearly 18% Today
2d
Y
Is This Dividend Stock a Buy Now After Falling Over 11% from Its 2026 Highs?
2d
Y
Herbalife (HLF) Q4 2025 Earnings Call Transcript
2d
Y
Why Riot Platforms Stock Zoomed Higher Today
2d
Y
Cheesecake Factory Q4 Earnings Call Highlights
2d
Y
Booking Q4 Earnings Call Highlights
2d
Y
eBay (EBAY) Q4 2025 Earnings Call Transcript
2d
Y
‘The world feels unpredictable’: I’m 56. My husband is 64. Our mortgage costs $17K a month. Do we pay it off?
2d
Y
Top Lawyers’ Fees Have Skyrocketed. Be Prepared to Pay $3,400 an Hour.
2d
Y
Analysts revamp Palantir stock rating
2d
Y
Down Nearly 40% From Its All-Time High, Is Netflix Stock Too Cheap to Ignore?
2d
Y
Bausch Health (BHC) Q4 2025 Earnings Transcript
2d
Y
Why Ferroglobe Stock Was a Winner on Wednesday
2d
Y
1 Reason Why Tesla Stock May Keep Underperforming
2d
Y
4 stocks to buy now (And 1 surprising sell)
2d
Y
Stock market today: Dow, S&P 500, Nasdaq futures edge lower with rate-cut bets, Walmart earnings in focus
2d
Y
Clean200 Tracks the Clean Economy and Fashion Barely Shows Up
2d
Y
Molson Coors Profit, Sales Fall as Beer Demand Remains Soft
2d
Y
Jack in the Box (JACK) Q1 2026 Earnings Transcript
2d
Y
TrueBlue (TBI) Q4 2025 Earnings Call Transcript
2d
Y
More →
